DOMINGO CALUZA SINGSON

Allopathic & Osteopathic Physicians|Family Medicine WILMINGTON, DE NPI 1275619652

General Payments — all program years on this page

$2,943.01

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 108
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $958.75 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $958.7541

By paying entity

Latest program year (PY2021) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $993.0531
2019 $680.7820
2020 $310.4316
2021 $958.7541

Records — PY2021 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
763466364 Boehringer Ingelheim Pharmaceuticals, Inc. $22.01 04/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
783653373 E.R. Squibb & Sons, L.L.C. $13.43 02/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
789105789 Bayer HealthCare Pharmaceuticals Inc. $15.93 10/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
789119413 Bayer HealthCare Pharmaceuticals Inc. $16.41 08/11/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
789161069 Bayer HealthCare Pharmaceuticals Inc. $19.31 09/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
796052441 AbbVie Inc. $12.65 06/25/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
801590555 GlaxoSmithKline, LLC. $14.21 02/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
801590801 GlaxoSmithKline, LLC. $22.88 03/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
801591893 GlaxoSmithKline, LLC. $16.71 05/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802060181 GlaxoSmithKline, LLC. $22.88 02/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802061481 GlaxoSmithKline, LLC. $19.07 05/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802156031 GlaxoSmithKline, LLC. $19.07 08/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802246693 GlaxoSmithKline, LLC. $25.52 03/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802265765 GlaxoSmithKline, LLC. $18.86 04/26/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802281394 GlaxoSmithKline, LLC. $23.67 07/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802857455 GlaxoSmithKline, LLC. $21.50 06/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
803072411 GlaxoSmithKline, LLC. $19.07 06/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
803113133 GlaxoSmithKline, LLC. $22.00 10/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
803204415 GlaxoSmithKline, LLC. $22.43 10/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810716067 Novo Nordisk Inc $19.48 02/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811066091 Novo Nordisk Inc $125.00 08/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811387247 Novo Nordisk Inc $115.00 06/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811658907 Novo Nordisk Inc $15.37 05/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
817835929 Eisai Inc. $12.18 02/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819082152 Lilly USA, LLC $26.00 01/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819095365 Lilly USA, LLC $24.00 03/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819113073 Lilly USA, LLC $15.82 08/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829396611 AstraZeneca Pharmaceuticals LP $16.76 04/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829635043 AstraZeneca Pharmaceuticals LP $19.65 07/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829724399 AstraZeneca Pharmaceuticals LP $20.87 05/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829812441 AstraZeneca Pharmaceuticals LP $21.38 10/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829879125 AstraZeneca Pharmaceuticals LP $14.15 08/18/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829950993 AstraZeneca Pharmaceuticals LP $19.61 03/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
830059813 AstraZeneca Pharmaceuticals LP $16.76 09/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
830071075 AstraZeneca Pharmaceuticals LP $21.27 11/08/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
830099949 AstraZeneca Pharmaceuticals LP $16.60 03/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833407473 PFIZER INC. $18.54 06/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833410239 PFIZER INC. $12.69 03/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833453909 PFIZER INC. $14.63 05/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833541385 PFIZER INC. $13.19 02/05/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848617735 Merck Sharp & Dohme Corporation $12.19 10/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.